The prospect of eliminating human rabies in China
10.3760/cma.j.cn112866-20240509-00082
- VernacularTitle:中国消除人间狂犬病的前景
- Author:
Chuanlin WANG
1
;
Wenwu YIN
Author Information
1. 北京大学人民医院急诊外科、创伤救治中心 创伤与神经再生教育部重点实验室（北京大学） 国家创伤医学中心，北京 100044
- Keywords:
Rabies;
Vaccine;
Post exposure prophylaxis;
Dog;
Immunization
- From:
Chinese Journal of Experimental and Clinical Virology
2024;38(4):369-372
- CountryChina
- Language:Chinese
-
Abstract:
Since 2007, the annual incidence of human rabies in China has been continuously decreasing, and China has entered the critical stage of eliminating human rabies. China will prioritize the control of rabies among dogs as the primary task for human rabies prevention and control, and implement surveillance and containment strategies, while also focusing on improving the standardization of post-exposure prophylaxis (PEP) for rabies. The sufficient production capacity of rabies immune preparations in China provides good biological product guarantee conditions for rabies prevention and control. However, dog management issues are prominent in China, not only affecting canine immunization, but also leading to a high number of canine injuries, resulting in huge costs for human rabies PEP. China lags behind in developing cheaper and more efficient rabies vaccines, which can help more rabies-exposed individuals obtain PEP. There are no insurmountable technical barriers in rabies prevention and control in China, and the prospect of achieving the elimination of human rabies by 2030 in China is promising.
